Trae Fitzgerald - 18 Jan 2025 Form 4/A - Amendment Insider Report for VIEMED HEALTHCARE, INC. (VMD)

Role
Chief Financial Officer
Signature
/s/ Jesse Bergeron, Attorney-in-Fact
Issuer symbol
VMD
Transactions as of
18 Jan 2025
Net transactions value
-$15,020
Form type
4/A - Amendment
Filing time
23 Jan 2025, 17:45:22 UTC
Date Of Original Report
22 Jan 2025
Previous filing
22 Jan 2025
Next filing
31 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VMD Common Shares Options Exercise +5,405 +7.4% 78,004 18 Jan 2025 Direct F1, F2
transaction VMD Common Shares Tax liability $15,020 -1,843 -2.4% $8.15 76,161 18 Jan 2025 Direct F1, F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VMD Restricted Stock Units Options Exercise $0 -5,405 -100% $0.000000 0 18 Jan 2025 Common Shares 5,405 Direct F1, F2, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This filing amends the Form 4 originally filed on filed on January 22, 2025, to report the payment of tax liability through the withholding of securities in connection with the vesting of restricted stock units on January 18, 2025.
F2 Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share.
F3 Shares that were withheld by the issuer to satisfy the reporting person's tax obligation resulting from the vesting of restricted stock units.
F4 Per share value is based on the market closing price of the common shares for January 17, 2025.
F5 Restricted Stock Units (RSUs) granted to reporting person on January 18, 2022, which vest in three equal annual installments beginning on the first anniversary of the grant date.